Doxazosin recalls

The FDA has published 13 recalls involving Doxazosin since 2012. The latest was reported on 18 Feb 2026. Most were for manufacturing (cgmp) deviations. Accord Healthcare has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls13since 2012

Last 12 months1reported

Class I00% of total

Ongoing4latest 18 Feb 2026

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 2 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 1Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 12 92%Class III 1 8%

Why doxazosin is recalled

Companies

Brands

By year

202618%
2025215%
2023862%
201418%
201218%

Ongoing doxazosin recalls

4 active

Reported	Class	Recall	Company	Reason	Where
18 Feb 2026Drug	CLASS III	Doxazosin Tablets, USP, 4 mg recalled by Unichem Pharmaceuticals USADoxazosin Mesylate	Unichem Pharmaceuticals USA	Other	Nationwide
3 May 2023Drug	CLASS II	Doxazosin Tablets, USP, 4mg recalled by Northwind PharmaceuticalsDoxazosin	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
12 Apr 2023Drug	CLASS II	Doxazosin Tablets, USP, 2 mg recalled by Preferred Pharmaceuticals	Preferred Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
12 Apr 2023Drug	CLASS II	Doxazosin Tablets, USP, 4 mg recalled by Preferred Pharmaceuticals	Preferred Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide

All doxazosin recalls, newest first

13 total

Reported	Class	Recall	Company	Reason	Where
18 Feb 2026Drug	CLASS III	Doxazosin Tablets, USP, 4 mg recalled by Unichem Pharmaceuticals USADoxazosin Mesylate	Unichem Pharmaceuticals USA	Other	Nationwide
22 Jan 2025Drug	CLASS II	Cardura XL (doxazosin) extended release tablets 4 mg recalled by ViatrisCardura	Viatris	Potency & Assay	Nationwide
22 Jan 2025Drug	CLASS II	Cardura XL (doxazosin) extended release tablets 8 mg recalled by ViatrisCardura	Viatris	Potency & Assay	Nationwide
3 May 2023Drug	CLASS II	Doxazosin Tablets, USP, 4mg recalled by Northwind PharmaceuticalsDoxazosin	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
12 Apr 2023Drug	CLASS II	Doxazosin 2 mg tablets, packaged in a) 30-count recalled by RemedyRepack	RemedyRepack	Manufacturing (CGMP) Deviations	Nationwide
12 Apr 2023Drug	CLASS II	Doxazosin Tablets, USP, 2 mg recalled by Preferred Pharmaceuticals	Preferred Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
12 Apr 2023Drug	CLASS II	Doxazosin Tablets, USP, 4 mg recalled by Preferred Pharmaceuticals	Preferred Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
8 Mar 2023Drug	CLASS II	Doxazosin Tablets USP, 4 mg recalled by Accord HealthcareDoxazosin	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
8 Mar 2023Drug	CLASS II	Doxazosin Tablets USP, 2 mg recalled by Accord HealthcareDoxazosin	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
8 Mar 2023Drug	CLASS II	Doxazosin Tablets USP 1 mg recalled by Accord HealthcareDoxazosin	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
8 Mar 2023Drug	CLASS II	Doxazosin Tablets USP, 8 mg recalled by Accord HealthcareDoxazosin	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
29 Jan 2014Drug	CLASS II	Doxazosin Mesylate, Tablet, 1 mg, Over The Counter recalled	Aidapak Services	Labeling Errors	4 states
31 Oct 2012Drug	CLASS II	Doxazosin Tablets, USP, 2 mg, labeled in part *** recalled	Mylan Pharmaceuticals	Foreign Material	Nationwide

Should you stop taking Doxazosin?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.